We wish to inform you that pursuant to Schedule IV of the Companies Act, 2013 and Regulation 25(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a Separate ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Trident Texofab Ltd has made a stock exchange filing referencing Schedule IV of the Companies Act, 2013 and Regulation 25(3) of the SEBI Listing Regulations, which together govern separate meetings of independent directors. The headline suggests the company is informing the exchange about a separate meeting of its independent directors, a routine corporate governance requirement. No financial numbers, business update, or strategic detail is available in the provided text. The linked BSE page returned an error and the full filing content could not be retrieved, so the specific date, agenda, or outcomes of the meeting are unknown.
This appears to be a routine regulatory compliance disclosure with no direct impact on shareholders or the stock price. Investors should watch for any follow-up announcements only if the independent directors raise material governance concerns.